血管压缩剂疗法是一种治疗方法
Jean-Louis Vincent1, Filippo Annoni1
1Department of Intensive Care, Erasme Hospital, Université libre de Bruxelles, 1070 Brussels, Belgium.
Journal of clinical medicine
|December 17, 2024
概括
血管压缩剂治疗对于通过维持血管和组织输液来管理休克患者至关重要. 上腺素是第一线选择,但考虑到血液动力学反应的个性化治疗是有效使用血管压缩剂的关键.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 血液动力学 血液动力学
背景情况:
- 血管压缩剂治疗对于经历冲击的重症监护患者至关重要.
- 保持足够的组织输液是管理休克的主要目标.
- 由于其有效性和安全性概况,诺拉上腺素是推的第一线血管压缩剂.
研究的目的:
- 审查在重症监护中使用的不同血管压缩剂.
- 强调调整血管压缩剂治疗以满足个体患者的需求和血液动力学反应.
- 讨论各种血管活性剂在管理冲击中的作用.
主要方法:
- 这项研究是一篇叙事性综述.
- 它综合了有关血管压缩剂的当前文献.
- 专注于临床应用和患者特定考虑.
主要成果:
- 上腺素提供可靠的血管收缩与最小的心率影响和轻微的内效应.
- 血管压素和血管素II在特定的血管扩张状态或高素状况中起作用,需要进一步的数据.
- 当氧气供应减少时,多布他胺有助于组织 perfusion,通常与持续的液体管理.
结论:
- 基于血液动力学反应的个性化血管压缩剂选择和定位对于最佳患者结果至关重要.
- 在使用任何血管压缩剂时,避免过度血管收缩至关重要.
- 对不同血管活性剂的全面了解可以在冲击管理中进行有针对性的治疗.
相关概念视频
Antihypertensive Drugs: Vasodilators
474
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
474
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
382
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
382
Heart Failure Drugs: β-Blockers
315
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
315
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
171
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
171
Adrenergic Agonists: Therapeutic Uses
725
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
725
Heart Failure Drugs: Diuretics
339
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
339


